Genomics knowledge and equity:a global public goods perspective of the patent system.
Genomics, the comprehensive examination of an organism's entire set of genes and their interactions, will have a major impact on the way disease is diagnosed, prevented and treated in the new millennium. Despite the tremendous potential it holds for improving global health, genomics challenges polic...
| Publicado en: | Bulletin of the World Health Organization Vol. 82; no. 5; pp. 385 - 390 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
World Health Organization
May2004
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106082045&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106082045 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00429686 BUW jtl: Bulletin of the World Health Organization issn: 00429686 maglogo: N pubinfo: dt: May2004 vid: 82 iid: 5 pid: 437 pub: World Health Organization artinfo: ui: 106082045 106082045 2009396438 NLM15298230 106082045 ppf: 385 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Genomics knowledge and equity:a global public goods perspective of the patent system. aug: au: Smith RB Thorsteinsdottir H Daar AS Gold ER Singer PA sug: subj: Genomics International Relations Patents Legislation and Jurisprudence Public Sector Social Justice World Health Health Policy Knowledge Resource Allocation Social Responsibility ab: Genomics, the comprehensive examination of an organism's entire set of genes and their interactions, will have a major impact on the way disease is diagnosed, prevented and treated in the new millennium. Despite the tremendous potential it holds for improving global health, genomics challenges policy-makers to ensure that its benefits are harnessed equitably across populations and nations. The classification of genomics as a global public good and the inequity encountered in the development and application of genomics knowledge are outlined in this paper. We examine the effect of the current patient system on the distribution of costs and benefits relating to genomics knowledge between countries of different economic strength. The global public goods concept provides a normative economic rationale for the modification of certain aspects of the current patent system and for the creation of complementary mechanisms to respond to the health needs of low-income and middle-income countries. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|